跳至主要内容
临床试验/IRCT20131229015975N5
IRCT20131229015975N5已完成2 期

Effect of dorzolamide drop with intravitreal avastin injection in decreasing central macular thickness in diabetic patient with diabetic macular edema

Esfahan University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 62 years(—)
性别
All

入选标准

  • Diabetic patients with retinopathy who have macular edema due to increased macular thickness or vision loss are indicative of anti-VEGF treatment.
  • A transparent mediator for a thorough examination
  • Visual activity of both eyes are better than 1/10 and less than 4/10
  • Patient consent to Participate in the Study
  • The thickness of the central area of the macula at the start of treatment is greater than 300 microns

排除标准

  • History of bone surgery
  • The presence of atrophy, scarring, fibrosis and hard exudates in the macular center that affects visual acuity.
  • Uncontrolled blood pressure
  • Presence of active eye infectious disease
  • There are other complications of diabetes in the eyes, which leads to an increase in the thickness of the macula.
  • The presence of other synchronous eye pathologies such as glaucoma and cataracts.

研究者

相似试验